Bank of New York Mellon Corp
BankPosition in LRMR — Larimar Therapeutics, Inc.
CIK 1390777
NEW YORK, NY
Position in LRMR
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$482,989
+$41,305 QoQ
Shares Held
107,331
-7.4% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in LRMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. LRMR ranks #207 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in LRMR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $482,989 | 107,331 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $441,684 | 115,928 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $358,658 | 111,040 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $288,677 | 99,889 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $215,973 | 100,453 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $388,751 | 100,453 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $646,026 | 98,630 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $977,858 | 134,877 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $651,031 | 85,775 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $440,275 | 96,764 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $386,459 | 97,838 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $306,232 | 97,838 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $130,540 | 28,817 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $119,013 | 28,817 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $60,713 | 18,973 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $37,186 | 18,973 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $76,840 | 18,973 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $204,718 | 18,973 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $218,758 | 18,973 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $186,314 | 18,973 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $277,194 | 18,973 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||